| 1 |
32930901 | In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line. | 2020 Sep 15 |
1 |
| 2 |
24213303 | Stimulatory effects of sorafenib on human non‑small cell lung cancer cells in vitro by regulating MAPK/ERK activation. | 2014 Jan |
1 |
| 3 |
22973961 | Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells. | 2013 |
1 |
| 4 |
22383427 | Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways. | 2012 Jun |
1 |
| 5 |
22641227 | Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma. | 2012 Aug |
1 |